Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berko

Showing results (211-220 of 238) with videos related to

Pageof 24
Sort By:
BMJ Global Health|February 12, 2025
Sickle cell retinopathy among Ghanaian high school students: a school-based screeningJessica Sedhom, Akwasi Ahmed, Andrew DesLauriers, et al.
Immunity, Inflammation and Disease|August 30, 2023
Receptors expressions on peripheral lymphocytes and CD4<sup>+</sup> CD183<sup>+</sup> as a diagnostics biomarker for rheumatoid arthritis: A case-control study in GhanaSamuel Asamoah Sakyi, Tonnies Abeku Buckman, Kwame Yeboah-Mensah, et al.
The American Journal of Pathology|April 17, 2010
2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristicsMarta Jeison, Shifra Ash, Gili Halevy-Berko, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 15, 2010
Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12Stefan Smesny, Christina Kunstmann, Sebastian Kunstmann, et al.
Alzheimer'S Research & Therapy|December 20, 2024
Analytical and clinical performance of eight Simoa<sup>®</sup> and Lumipulse<sup>®</sup> assays for automated measurement of plasma p-tau181 and p-tau217Anna L Wojdała, Jeroen Vanbrabant, Sherif Bayoumy, et al.
Pharmacological Research|November 20, 2001
Screening for cerebroprotective agents using an in vivo model of cerebral reversible depolarization in awake ratsM Bodo, G Perjes, E Kalman, et al.
Plos One|February 20, 2016
Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for PsychosisGregor E Berger, Stefan Smesny, Miriam R Schäfer, et al.
Open Forum Infectious Diseases|July 20, 2022
Cryptococcal and <i>Histoplasma</i> Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx <i>Histoplasma</i> Lateral Flow Assay and IMMY <i>Histoplasma</i> Enzyme ImmunoassayBright K Ocansey, Benjamin Otoo, Isabella Asamoah, et al.
Environmental Science & Technology|October 8, 2009
Terpenylic acid and related compounds from the oxidation of alpha-pinene: implications for new particle formation and growth above forestsMagda Claeys, Yoshiteru Iinuma, Rafal Szmigielski, et al.
The Journal of Prevention of Alzheimer'S Disease|February 15, 2025
Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's diseaseErika N Cline, Daniel Antwi-Berko, Karen Sundell, et al.
Pageof 24

Showing results (211-220 of 238) with videos related to

Sort By:
Pageof 24
BMJ Global Health|February 12, 2025
Sickle cell retinopathy among Ghanaian high school students: a school-based screeningJessica Sedhom, Akwasi Ahmed, Andrew DesLauriers, et al.
Immunity, Inflammation and Disease|August 30, 2023
Receptors expressions on peripheral lymphocytes and CD4<sup>+</sup> CD183<sup>+</sup> as a diagnostics biomarker for rheumatoid arthritis: A case-control study in GhanaSamuel Asamoah Sakyi, Tonnies Abeku Buckman, Kwame Yeboah-Mensah, et al.
The American Journal of Pathology|April 17, 2010
2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristicsMarta Jeison, Shifra Ash, Gili Halevy-Berko, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 15, 2010
Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12Stefan Smesny, Christina Kunstmann, Sebastian Kunstmann, et al.
Alzheimer'S Research & Therapy|December 20, 2024
Analytical and clinical performance of eight Simoa<sup>®</sup> and Lumipulse<sup>®</sup> assays for automated measurement of plasma p-tau181 and p-tau217Anna L Wojdała, Jeroen Vanbrabant, Sherif Bayoumy, et al.
Pharmacological Research|November 20, 2001
Screening for cerebroprotective agents using an in vivo model of cerebral reversible depolarization in awake ratsM Bodo, G Perjes, E Kalman, et al.
Plos One|February 20, 2016
Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for PsychosisGregor E Berger, Stefan Smesny, Miriam R Schäfer, et al.
Open Forum Infectious Diseases|July 20, 2022
Cryptococcal and <i>Histoplasma</i> Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx <i>Histoplasma</i> Lateral Flow Assay and IMMY <i>Histoplasma</i> Enzyme ImmunoassayBright K Ocansey, Benjamin Otoo, Isabella Asamoah, et al.
Environmental Science & Technology|October 8, 2009
Terpenylic acid and related compounds from the oxidation of alpha-pinene: implications for new particle formation and growth above forestsMagda Claeys, Yoshiteru Iinuma, Rafal Szmigielski, et al.
The Journal of Prevention of Alzheimer'S Disease|February 15, 2025
Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's diseaseErika N Cline, Daniel Antwi-Berko, Karen Sundell, et al.
Pageof 24